TimesSquare Capital Management LLC purchased a new position in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 175,869 shares of the company’s stock, valued at approximately $84,948,000. Astera Labs accounts for about 1.2% of TimesSquare Capital Management LLC’s portfolio, making the stock its 21st biggest position. TimesSquare Capital Management LLC owned about 0.10% of Astera Labs as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors have also recently made changes to their positions in the company. Eurizon Capital SGR S.p.A. purchased a new stake in Astera Labs during the 4th quarter valued at $18,708,000. Swedbank AB raised its position in shares of Astera Labs by 76.8% during the 4th quarter. Swedbank AB now owns 78,140 shares of the company’s stock valued at $12,999,000 after purchasing an additional 33,940 shares during the period. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. bought a new stake in Astera Labs during the 4th quarter valued at approximately $499,000. Revere Asset Management Inc purchased a new stake in Astera Labs in the 4th quarter worth $589,000. Finally, Mitsubishi UFJ Trust & Banking Corp purchased a new stake in Astera Labs during the fourth quarter valued at $10,299,000. Institutional investors own 60.47% of the company’s stock.
Insider Activity at Astera Labs
In related news, Director Manuel Alba sold 136,974 shares of Astera Labs stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the sale, the director directly owned 1,287,524 shares in the company, valued at $569,098,483.24. This trade represents a 9.62% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the firm’s stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $311.83, for a total value of $1,092,964.15. Following the transaction, the director owned 53,961 shares in the company, valued at $16,826,658.63. This represents a 6.10% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 631,979 shares of company stock worth $215,479,247 in the last ninety days. Company insiders own 10.40% of the company’s stock.
Astera Labs Trading Down 0.4%
Astera Labs (NASDAQ:ALAB – Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The business had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. During the same period in the previous year, the firm posted $0.44 earnings per share. The company’s revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Research analysts predict that Astera Labs, Inc. will post 2.7 EPS for the current year.
Analyst Upgrades and Downgrades
ALAB has been the subject of a number of research reports. Barclays boosted their price target on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a report on Monday, July 20th. Northland Securities raised shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 price target on the stock in a report on Monday. Rothschild & Co Redburn initiated coverage on shares of Astera Labs in a report on Friday, May 1st. They set a “neutral” rating and a $153.00 price objective on the stock. Stifel Nicolaus raised their target price on Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a research note on Wednesday, June 24th. Finally, Needham & Company LLC upped their target price on Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a research note on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eight have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $333.00.
Check Out Our Latest Stock Analysis on ALAB
Astera Labs Company Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Read More
- Five stocks we like better than Astera Labs
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
